biotech santé | e.c. and n.i.h. projects : double your funding opportunities by claire skentelbery...

Les points sur les i

Dr Claire SKENTELBERY – Secretary General, European Biotechnology Foundation Prof. J. BALTHAZART and Dr Julie BAKKER, ULg-GIGA Neurosciences Isabelle RAUSIN, ULg-Interface and Jérôme EECKHOUT, ULg-ARD

Health researchers : double your funding opportunities and those of your U.S. partners, by targeting jointly E.C. and N.I.H. projects

Avec le soutien de :

15.2.2012 www.european-biotechnology.net 1

Building transatlantic research partnerships Claire Skentelbery European Biotechnology Network

Mission for today

•  Introduce European Biotechnology Network •  Understand tools available to build US

research partnerships •  Suitability for your work •  Plan 2012 opportunities •  Get to work!

15.2.2012 www.european-biotechnology.net 2

Getting introduced

•  Cross sectoral network in biotech •  Mission to facilitate partnership •  Delivering biotechnology – critical mass,

accelerated pace •  Biotechnology Funding Hub •  Strong focus on SME/industry inclusion •  Global focus for Europe

15.2.2012 www.european-biotechnology.net 3

Liege as a Network member •  For researchers and support staff •  Sign up to the Network each and every one! •  Free subscription to European Biotechnology

News – sign up to get your personal copy •  Funding Hub news – get the latest updates •  Free access to Network events/training •  Priority speaker places at events •  Direct assistance in project development •  Hub around which we can build projects

15.2.2012 www.european-biotechnology.net 4

Offer today •  Doing the business in the US!

–  March 29th, Brussels –  Small intensive workshop –  Logistics of building a successful US partnership –  €100 Corporate members

•  Building Transatlantic partnerships –  March 30th, Brussels –  NIH, EC, DoD, Gates Foundation –  Broader look at funding and experiences –  2 free places for Corporate members

15.2.2012 www.european-biotechnology.net 5

Biotechnology Funding Hub

•  Track funding open to SMEs in Europe; EC, Eurostars, eurotransbio, NIH, DoD

•  Mission to build collaborative partnerships •  Work with members to find projects and

develop proposals •  Training/advice/signposting •  Skype/phone surgeries

15.2.2012 www.european-biotechnology.net 6

Opportunities

•  National Institutes of Health

•  Department of Defense

•  Last call in FP7

15.2.2012 www.european-biotechnology.net 7

DoD 2012 – in a nutshell •  Secret funding tool – wide funding range •  Projects, fellowships – open to global application •  Few active in Europe, almost all in UK •  Significant opportunities for partnered applications:

–  Across all biology –  Diagnostics, vaccines, disease management, real

time & remote technologies –  Projects in Europe include breast cancer,

immunotherapy, lung cancer etc. 8 topics currently open

www.grants.gov 15.2.2012 www.european-biotechnology.net 8

FP7 2012 – in a nutshell

– Last call in 2012 – Lots of support in Liege – Opportunity to engage US partners for EC

projects - € directly from Brussels – Strong SME partnership opportunity – EBN working with NIH to matchmake

research for FP7

15.2.2012 www.european-biotechnology.net 9

NIH: Where to start? •  NIH enormous research and funding platform •  Aim of talk to address from practical perspective

–  What is it? –  Opportunities for me –  How to access projects –  Chances of success –  Best approach –  Finding partners –  Who can help me?

15.2.2012 www.european-biotechnology.net 10

What is NIH? •  NIH’s mission is to seek fundamental knowledge about

the nature and behaviour of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability.

•  Broad programme – basic-applied/clinical research •  $31.2 billion annual budget – squeezed in 2011/12

15.2.2012 www.european-biotechnology.net 11

Institutes of the NIH

•  27! •  Cancer, eye, Heart lung and blood, human genome,

ageing, alcohol abuse, allergy & infectious disease, arthritis & skin disease, imaging and bioengineering, child health, deafness & communication disorders, dental & craniofacial, diabetes, digestive & kidney diseases, drug abuse, env health, general medical sciences, mental health, neurological disorders & stroke, nursing, rare/neglected diseases

•  New - National Center for Advancing Translational Sciences’

15.2.2012 www.european-biotechnology.net 12

Each Institute has…

•  Own mission and structure •  Own research funding programme and budget •  Dedicated funding or joint funding with other

Institutes •  Budget varies hugely

15.2.2012 www.european-biotechnology.net 13

Opportunities open for me?

•  Focus on main funding programmes suitable •  Programmes launched – open 4 years •  3 deadlines/year – multiple application

opportunities •  Main programmes open to non-US application For non-US success, must either:

– Be not available in US – Significant benefit to US research

15.2.2012 www.european-biotechnology.net 14

Programme announcements (PA) •  General areas of high priority •  Proposals submitted at any time of year •  Evaluated 3 times/year •  Evaluation timescale:

– Scientific merit review: 2-3 months – Advisory Council: 4-5 months – Earliest start: 6-7 months

720 PAs open NOW!

15.2.2012 www.european-biotechnology.net 15

Requests for Application (RFA)

•  More specific research applications •  Often single deadline

92 RFAs open now!

15.2.2012 www.european-biotechnology.net 16

Project types - R21

– Exploratory, groundbreaking research – Max 2 years – Max $275,000 – Encouraged to contact NIH during

development stage

15.2.2012 www.european-biotechnology.net 17

Project types – R01 –  ‘Original’ proposal type –  PI nominates topic and focus within programme

announcement –  Covers salary, equipment, consultants, contract

services, indirect costs, travel –  No max cost BUT:

•  €25,000 modules up to module limit of $250k •  Max 5 periods – usually 12 months each •  All non-US applicants must have detailed budget

–  1 resubmission allowed –  Encouraged to contact NIH

15.2.2012 www.european-biotechnology.net 18

Project types - P01

•  Research program projects •  Broad based •  Multidisciplinary •  Long term •  All address different elements of common

objectives •  Industry encouraged – non-US also •  No budget max unless stated

15.2.2012 www.european-biotechnology.net 19

Funding level/success rates? Varies between Institute: 2010 examples •  NCI: 17% - $516 million •  NIAID (allergy/infectious disease): 24% - $506 million •  NHLBI (heart/lung/blood): 20% - $416 million •  NIGMS (general): 27% - $336 million •  NIDDK (diabetes/digestive/kidney): 26% - $333 million This counts project renewal: higher % for those New project: More like 10% success

15.2.2012 www.european-biotechnology.net 20

Proposal contents

•  Pleasingly similar between all! •  Get familiar with PHS398 – core example

15.2.2012 www.european-biotechnology.net 21

Proposal core elements – Budget for initial/whole – Research plan:

• Aims • Strategy – see next slide •  Inclusion – women/minorities • Enrolment • Agent research • Leadership plan • Consortium/contractual plan

15.2.2012 www.european-biotechnology.net 22

Research strategy contents

•  Significance (problem, scientific advance, impact)

•  Innovation (changes to current practice, novelty and advantage)

•  Approach (strategy, method, analyses, data collection, risk management, hazards)

•  Preliminary studies for new applications No max length: detailed, clear and concise!

15.2.2012 www.european-biotechnology.net 23

Example Programme announcement

15.2.2012 www.european-biotechnology.net 24

PA cont

15.2.2012 www.european-biotechnology.net 25

PA cont

15.2.2012 www.european-biotechnology.net 26

Quick summary

•  Each call VERY detailed •  Expectations listed •  Eligibility defined •  Direct contact details for each •  Deadlines •  All hyperlinked

15.2.2012 www.european-biotechnology.net 27

Information overload?

•  Looked at: –  Institutes – Funding programmes – Project types – Success rates

•  What now?

15.2.2012 www.european-biotechnology.net 28

If I was doing this…….

•  First time European applicant? •  Find suitable call topic •  Find European organisations already playing in

US – several in the room! •  Find US partners you KNOW and are active in

NIH •  Understand history of funding in this area •  Try and join/develop US-led proposal •  Go prepared to a key US conf and partner

15.2.2012 www.european-biotechnology.net 29

Resources to use

•  Searchable database on NIH website http://projectreporter.nih.gov/reporter.cfm •  Many funding reports available •  Find groups active in your field – great starting

point

15.2.2012 www.european-biotechnology.net 30

15.2.2012 www.european-biotechnology.net 31

Thank you"

Good hunting!"